Biosimilar Utilization Increased During the OCM and Generated Savings
June 23rd 2022Abstracts presented at the American Society of Clinical Oncology Annual Meeting evaluated biosimilar use in practices participating in the Oncology Care Model (OCM) and estimated the savings as a result of substituting these agents for more expensive reference products.
Read More
Study Highlights Need for Validated Blood Biomarkers in PAH
June 23rd 2022Collecting more than 3 decades’ worth of data, researchers determined that none of the identified blood biomarkers are accurate enough to take the place of current diagnostic approaches, either due to lack of data or lack of specificity.
Read More
The Supreme Court, in a 6-3 decision, ruled that New York's requirement for concealed carry gun permits are too restrictive; the FDA ordered Juul Labs Inc to pull its e-cigarettes from the market; a meningococcal disease outbreak in Florida includes at least 26 total cases and 7 deaths.
Read More
Women “Significantly” More Likely to Develop Long COVID, Review Finds
June 22nd 2022The study, published in Current Medical Research and Opinion, finds that females were 22% more likely than males to have long COVID, which was defined as having symptoms that lasted more than 4 weeks after onset.
Read More
Patients With HFrEF May Benefit From Alternate Method of Sac/Val Dose Titration
June 22nd 2022In this study, Italian investigators evaluated how sacubitril/valsartan (Sac/Val) dose titration among older patients with heart failure with reduced ejection fraction (HFrEF) might affect reverse cardiac remodeling and if the success of up-titration can be predicted.
Read More
Dr Hatem Soliman Explains How the DNA Damage Repair Pathway Affects Cancer Progression
June 22nd 2022It is important that we learn how to exploit DNA damage repair deficiencies to treat cancer help patients in control their disease. explained Hatem Soliman, MD, medical director, Clinical Trials Office, Moffitt Cancer Center.
Watch
Caregivers of Children With Asthma Lack Knowledge About Disease Management
June 22nd 2022About 70% of caregivers studied reported that they preferred to use the emergency department for treatment for asthma exacerbations, indicating current education is insufficient for managing asthma at home.
Read More
Analysis Finds Ranibizumab PDS Cost-Saving in Long-term Scenarios
June 22nd 2022A recent study found that the ranibizumab port delivery system (PDS) has cost-saving potential compared with regular ranibizumab or aflibercept injections for age-related macular degeneration if used in the long term.
Read More
Biologic Switching Patterns, Discontinuation in Psoriasis Investigated in New Study
June 22nd 2022An analysis of biologic drug use patterns in patients with psoriasis from Tuscany, Italy, associated etanercept with the highest frequency of switching to other biologics; secukinumab and ustekinumab were linked with the lowest risk.
Read More
What We’re Reading: FDA to Cut Nicotine Levels; Insulin Pricing Bill; DaVita Loses Dialysis Case
June 22nd 2022The FDA plans to set a maximum nicotine level in cigarettes and tobacco products to reduce addictiveness; a bipartisan bill would place a $35 monthly cap on insulin for patients with private insurance or Medicare; the Supreme Court ruled that an Ohio hospital’s employee health plan did not violate federal law by limiting coverage for outpatient dialysis.
Read More
Self-administration of Biologics Well Tolerated, Effective for Asthma and CRS With Nasal Polyps
June 22nd 2022The adequate safety and improved symptom burden observed with self-administration of biologic therapies at home for the management of severe asthma and chronic rhinosinusitis with nasal polyps suggests potential in shifting care away from the more costlier in-patient setting.
Read More
Generic Drug Savings Possibilities: $3.6 Billion to Medicare Using DTC Pricing
June 22nd 2022How much would have Medicare saved if it had the same ability to purchase generic drugs at the same price as individuals using direct-to-consumer (DTC) pharmacies like the Mark Cuban Cost Plus Drug Company? Billions, as it turns out.
Listen
Alignment Between Manufacturers, Payers Key to Improving Specialty Drug Affordability and Access
June 22nd 2022Panelists taking part in an AHIP 2022 session discuss collaborative strategies among payers, manufacturers, and policy makers to address challenges regarding affordability and access of novel disease modifying drugs entering the marketplace.
Read More
There Is More to Blame Than Tech for T1D Outcomes Disparities, Investigators Argue
June 21st 2022Investigators from the Pediatric Diabetes Center at Hassenfeld Children’s Hospital at NYU Langone investigated outcomes disparities as they related to diabetes technology use among youth living with type 1 diabetes (T1D).
Read More
Homeless people in the county of Phoenix, Arizona, made up 130 of the 339 who died of heat-associated causes in 2021; patients who are addicted to opioids may lose online help if federal regulations expire; Paul M Ellwood Jr, MD, the creator of the health maintenance organization (HMO) concept, died aged 95 years.
Read More